Back to search

National and Kapodistrian University of Athens

Ορμόνες του λιπώδους ιστού, φλεγμονώδεις παράγοντες, διαταραχές αιμόστασης και μη μικροκυτταρικός καρκίνος του πνεύμονα

Abstract

dc:description

Objectives: Chemerin and PAI-1 are emerging biomarkers at the intersection of inflammation, chemotaxis, thrombosis, fibrinolysis and metabolism. The aims of the present thesis were: 1) to explore the association between circulating chemerin and PAI-1 activity in resectable non-small cell lung cancer (NSCLC); 2) to study their diagnostic potential; and 3) to assess their associations with clinicopathological features of NSCLC. Methods: In an adequately powered case-control study, plasma PAI-1 activity, chemerin, metabolic parameters, classic adipokines, hemostatic, inflammatory and tumor biomarkers were measured in 110 consecutive patients with resectable NSCLC and 110 healthy subjects matched on age, sex and date of blood draw.Results: NSCLC patients exhibited significantly higher PAI-1 activity and serum chemerin levels compared to controls (p<0.001). In NSCLC cases, PAI-1 activity correlated with somatometric variables, insulin, WBC, antithrombin III, protein C, plasminogen, IL-6 and tumor size, whereas chemerin with Homeostasis model assessment score of insulin resistance (HOMA-IR), fibrinogen, plasminogen activity, tumor and inflammatory biomarkers, adiponectin, number of infiltrated lymph nodes and NSCLC stage. (p<0.05). Plasma PAI-1 activity and serum chemerin were independently associated with NSCLC beyond and above established risk factors for NSCLC (p<0.001). Plasminogen activity and body mass index emerged as independent predictors of PAI-1 activity in cases, whereas hemostatic parameters (platelet count and plasminogen activity), HOMA-IR, CYFRA 21-1, creatinine and plant food consumption emerged as independent predictors of circulating chemerin (p<0.05). Due to their high specificity, PAI-1 activity and serum chemerin could represent potentially useful parameters in ruling out NSCLC, alone or in combination with serum tumor markers associated with NSCLC. Conclusions: PAI-1 activity and serum chemerin may represent potentially useful biomarkers in NSCLC associated with thrombotic, tumor-promoting and metabolic networks. More clinical studies are needed to explore whether PAI-1 activity and chemerin may be practical biomarkers in the risk assessment of NSCLC at the crossroads of hemostasis, inflammation and metabolism.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Sotiropoulos, Georgios
  • Σωτηρόπουλος, Γεώργιος

Subjects

dc:subject × 7

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47015

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Sotiropoulos, Georgios; Σωτηρόπουλος, Γεώργιος. Ορμόνες του λιπώδους ιστού, φλεγμονώδεις παράγοντες, διαταραχές αιμόστασης και μη μικροκυτταρικός καρκίνος του πνεύμονα. National and Kapodistrian University of Athens, 2020. http://hdl.handle.net/10442/hedi/47015